GALWAY, Ireland , Aug. 20, 2026 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 20, 2026, approved the company's cash dividend for the second quarter of fiscal...
The BACKBEAT global pivotal trial (“BACKBEAT Trial”), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary...
Sphere-9 all-in-one mapping and ablation, large-tip focal, dual energy catheter first to be CE Marked for ventricular ablation
/Medtronic%20Plc%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Medtronic has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
/Intuitive%20Surgical%20Inc%20location%20sign-by%20Sundry%20Photography%20via%20iStock.jpg)
J&J’s Ottava clearance knocked Intuitive's shares lower, but recurring revenue and surgeon switching costs suggest the market overreacted.
/Medtronic%20sign%20seen%20at%20its%20Irvine%20office_By%20Tada%20Images.jpeg)
: Medtronic is set to report Q1 earnings, with analysts expecting high single-digit year-over-year EPS growth.
Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure
GALWAY, Ireland , July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1,...
Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.
Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹